peji_banner

nhau

Mishonga mishanu yekurapa uremu muvarwere vakuru vane yekutanga kufutisa-Semaglutide.

I. Basic Information
Generic Zita: Semaglutide
Rudzi: GLP-1 receptor agonist (yakareba-inobata glucagon-yakafanana peptide-1 analogi)
Routine of Administration: Subcutaneous jekiseni (kamwe pavhiki)

II. Zviratidzo uye Chimiro cheMvumo yeMumba
Zvakatenderwa Zviratidzo
Type 2 Diabetes Treatment (Yakatenderwa neNMPA):
Chiyero: 0.5 mg kana 1.0 mg, kamwe chete pavhiki.

Zviito: Inogadzirisa shuga yeropa uye inoderedza njodzi yemoyo.

Kufutisa/Kufutisa Kurapa

III. Mechanism of Action uye Efficacy
Core Mechanism: Inomutsa GLP-1 receptors, inononoka kubuda mudumbu, uye inowedzera kuguta.

Inoshanda pane hypothalamic appetite centre, inhibiting appetite.

Inovandudza insulin senitivity uye inogadzirisa metabolism.

Kurasikirwa Kwehuremu Kushanda (Kubva pamiyedzo yekiriniki yepasi rose):
Avhareji yekurasikirwa kwemasvondo e68: 15% -20% (pamwe chete nemararamiro ekupindira).

Vasiri vane chirwere cheshuga (BMI ≥ 30 kana ≥ 27 vane matambudziko):

Varwere vane chirwere cheshuga: zvishoma kuderera uremu mhedzisiro (inenge 5% -10%).

IV. Inoshanda Population uye Contraindications
Applicable Population
International Standards (ona WHO):
BMI ≥ 30 (yakafuta);
BMI ≥ 27 ine hypertension, chirwere cheshuga, kana zvimwe zvirwere zvemetabolism (kuwandisa).

Kudzidzira Kwemumba: Inoda kuongororwa kwechiremba; pari zvino inonyanya kushandiswa pakugadzirisa uremu muvarwere vane chirwere cheshuga.

Contraindications
Nhoroondo yemunhu kana yemhuri ye medullary thyroid carcinoma (MTC);
Multiple endocrine neoplasia syndrome rudzi rwechipiri (MEN2);
Vakadzi vane pamuviri kana vanoyamwisa;
Zvirwere zvakanyanya mudumbu (zvakadai senhoroondo yepancreatitis).

V. Zvikonzero uye Njodzi
Zvinowanzoitika mhedzisiro (zviitiko> 10%):
Nausea, kurutsa, manyoka, kuvimbiswa (kuderedzwa nekushandisa kwenguva refu).

Kuderera kwekuda kudya, kuneta.

Njodzi Dzakakura:

Thyroid C-cell tumors (njodzi dzinoratidzwa muzvidzidzo zvemhuka, zvisati zvanyatsojeka muvanhu);
Pancreatitis, gallbladder chirwere;
Hypoglycemia (kuchenjerera kunodiwa kana ichishandiswa pamwe chete nemamwe majekiseni e hypoglycemic).

VI. Ikozvino Kushandiswa muChina

Nzira dzekuwana:
Diabetes Treatment: Kunyorerwa kubva kuchipatara chenguva dzose.
Kurapa Kurasikirwa Kwehuremu: Inoda kuongororwa kwakasimba nachiremba; mamwe madhipatimendi endocrinology ezvipatara zvepamusoro anogona kuzvirayira.

Njodzi Dzinobva Kunzira Dzisina Kurongeka: Mishonga inotengwa nenzira isiri yepamutemo inogona kunge iri yemanyepo kana kuchengetwa zvisina kufanira, zvichiunza njodzi yekuchengetedza.

VII. Mashandisiro Mazano

Nyatsotevedzera Chirevo chaChiremba: Shandisa chete mushure mekunge chiremba aongorora zviratidzo zvemetabolism uye nhoroondo yemhuri yekurapa.

Yakasanganiswa Mararamiro Kupindira: Mishonga inoda kusanganiswa nekutonga kwekudya uye kurovedza muviri kuti uwane mhedzisiro yakakwana.

Kuongorora Kwenguva Yakareba: Gara uchitarisa thyroid basa, pancreatic enzymes, uye chiropa uye itsvo basa.


Nguva yekutumira: Nov-03-2025